Particulars |
|
|
|
Company Name
| Piramal Pharma Ltd
| Year End
| 202403
|
Full Year |
Equity (₹ Cr.) |
1,325.75 |
B.V. (₹) |
52.90 |
Sales(₹ Cr.) |
4,390.11 |
NP (₹ Cr.) |
387.88 |
NP Var (%) |
434.00 |
Div% |
1.00 |
CPS(₹) |
4.50 |
EPS (₹) |
2.90 |
Traded Value(₹ Lakhs) |
235.66 |
52 Week High |
308.00 |
52 Week Low |
136.00 |
Price BSE |
208.00 |
Price NSE |
208.00 |
Market Capital (₹ Cr.) |
27,562.30 |
P/C Ratio |
46.50 |
P/E Ratio |
71.10 |
Price Vs.BV |
3.93 |
|
Latest Quarter |
Year End |
202412 |
Sales (₹ Cr.) |
1,248.32 |
NP(₹ Cr.) |
118.80 |
NP Var % |
60.00 |
Trailing Twelve Months |
Year End |
202412 |
Sales |
4,897.03 |
OPM |
18.78 |
NP |
642.75 |
NP Var (%) |
329.94 |
EPS |
5.18 |
PE |
40.14 |
|
|